Liuyi Lu
Impact in
- Nutrition and Dietetics top 10%
- Trace Elements in Health
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- ATP Synthase and ATPases Research 3
- Genomics and Phylogenetic Studies 2
- RNA modifications and cancer 2
- Advanced biosensing and bioanalysis techniques 1
-
- Atherosclerosis and Cardiovascular Diseases 2
- interferon and immune responses 2
- Co-authors
- Yuemin Ding (3 shared papers)Peijie Zheng (2 shared papers)Bin Liu (1 shared paper)Feng Zhu (1 shared paper)Shiwei Duan (2 shared papers)Junmeng Zheng (5 shared papers)Jie Liu (1 shared paper)Guan‐Lei Wang (1 shared paper)
- Journals
- Oxidative Medicine and Cellular Longevity (2 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (1 paper)Frontiers in Plant Science (1 paper)Acta Pharmacologica Sinica (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Liuyi Lu
15 papers receiving 370 citations
Liuyi Lu's Hit Papers
Peers
Comparison fields: 5 of 74
- Nutrition and Dietetics 88
- Cancer Research 86
- Neurology 21
- Pulmonary and Respiratory Medicine 74
- Complementary and alternative medicine 18
Countries citing papers authored by Liuyi Lu
This map shows the geographic impact of Liuyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuyi Lu more than expected).
Fields of papers citing papers by Liuyi Lu
This network shows the impact of papers produced by Liuyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuyi Lu. The network helps show where Liuyi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Liuyi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy Hit paper breakdown → | 2022 | 210 |
| 2 | 2017 | 40 | |
| 3 | 2023 | 33 | |
| 4 | 2021 | 19 | |
| 5 | 2022 | 16 | |
| 6 | 2019 | 12 | |
| 7 | 2022 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2020 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2024 | 1 |
About Liuyi Lu
Liuyi Lu is a scholar working on Molecular Biology, Immunology, Cancer Research, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 16 papers that have together received 376 indexed citations. Recurring topics across this work include ATP Synthase and ATPases Research (3 papers), Genomics and Phylogenetic Studies (2 papers), Neurological Disease Mechanisms and Treatments (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), interferon and immune responses (2 papers), RNA modifications and cancer (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Plant-Microbe Interactions and Immunity (1 paper). The work is most often cited by research in Nutrition and Dietetics (88 citations), Cancer Research (86 citations), Neurology (21 citations), Pulmonary and Respiratory Medicine (74 citations) and Complementary and alternative medicine (18 citations). Liuyi Lu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yuemin Ding, Peijie Zheng, Bin Liu, Feng Zhu, Shiwei Duan, Junmeng Zheng, Jie Liu, Guan‐Lei Wang, Mei Li and Xuejun Wen. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Naunyn-Schmiedeberg s Archives of Pharmacology, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Frontiers in Plant Science and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.